Talon Therapeutics

FDA approves Marqibo for rare type of leukemia

Thursday, August 9, 2012

The FDA approved Talon Therapeutics’ Marqibo (vincristine sulfate liposome injection) to treat adults with a rare type of leukemia called Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL), a rapidly progressing form of blood and bone marrow cancer that is more commonly diagnosed in children than adults.

[Read More]